Kanoya and Nocheng Jianhua jointly announced the licensing cooperation on CD20xCD3 bispecific antibody with Prolium

The content is for reference only, not a solicitation or offer. No investment, tax, or legal advice provided. See Disclaimer for more risks disclosure.